Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2007 by Hospices Civils de Lyon.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Hospices Civils de Lyon

ClinicalTrials.gov Identifier:

NCT00146926

First received: September 5, 2005

Last updated: April 26, 2007

Last verified: April 2007

History of Changes

Purpose

Propofol is a popular intravenous drug to induce anesthesia but it causes local pain with an incidence between 40 and 90%. Three different strategies to prevent propofol induced pain will be studied compared with placebo. Pain will be scored with a four-point scale.

Condition	Intervention	Phase
Induction of Total Intravenous General Anesthesia	Drug: kétamine 20mg Drug: ephedrine 3mg Drug: lidocaine 40mg	Phase 3


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double-Blind
Official Title:	Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion

Resource links provided by NLM:

Drug Information available for: Lidocaine Propofol Ketamine

U.S. FDA Resources

Further study details as provided by Hospices Civils de Lyon:

Primary Outcome Measures:

After prophylactic solution, evaluation of the pain caused by injection of propofol with a four-point scale before lose of consciousness

Secondary Outcome Measures:

Explicite and implicite memory of pain immediately after surgery and on day one
Adverse effects


Estimated Enrollment:	200
Study Start Date:	September 2005

Eligibility


Ages Eligible for Study:	18 Years to 75 Years (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Healthy adults (ASA 1-2) for scheduled surgery under general anesthesia with propofol

Exclusion Criteria:

pregnant
sedative or analgesic drug 24h before surgery
allergy with drug used in the study
difficulty of communication
absence of informed written consent

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00146926

Locations


France
Grégoire CHATAIN
Lyon, France, 69495

Sponsors and Collaborators

Hospices Civils de Lyon

Investigators


Principal Investigator:	Vincent PIRIOU, MD	Hospices Civils de Lyon

More Information


ClinicalTrials.gov Identifier:	NCT00146926 History of Changes
Other Study ID Numbers:	2004.367
Study First Received:	September 5, 2005
Last Updated:	April 26, 2007
Health Authority:	France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by Hospices Civils de Lyon:


Propofol pain general anesthesia prevention

Additional relevant MeSH terms:


Lidocaine Propofol Ketamine Ephedrine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents Anti-Arrhythmia Agents Voltage-Gated Sodium Channel Blockers Sodium Channel Blockers Membrane Transport Modulators	Molecular Mechanisms of Pharmacological Action Hypnotics and Sedatives Anesthetics, Intravenous Anesthetics, General Analgesics Anesthetics, Dissociative Excitatory Amino Acid Antagonists Excitatory Amino Acid Agents Neurotransmitter Agents Central Nervous System Stimulants Sympathomimetics Autonomic Agents Vasoconstrictor Agents Adrenergic Agents

ClinicalTrials.gov processed this record on September 23, 2016

To Top